Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Indigotindisulfonate sodium, commonly known as Indigo Carmine, is a small molecule diagnostic dye used as a visualization aid in various medical and surgical procedures. It is a dark blue dye that, when administered intravenously, is rapidly filtered by the kidneys and excreted into the urine, retaining its intense blue color. This property allows for the cystoscopic assessment of ureteral integrity and patency following urological and gynecological surgeries. In July 2022, the FDA approved Bludigo (developed by Provepharm) as the first standardized injectable form for this indication. Beyond urology, the dye is extensively used in gastroenterology for diagnostic chromoendoscopy, where it is applied topically to the mucosal surface to enhance the detection of lesions, polyps, and dysplasia by pooling in surface irregularities. It is also utilized in brain tumor margin delineation and rectal cancer lymph node staging, and serves as a widely used food colorant (FD&C Blue #2 in the US and E132 in the EU).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on indigotindisulfonate sodium.